164 related articles for article (PubMed ID: 36237985)
1. Analysis of the efficacy of autologous peripheral blood stem cell transplantation in high-risk neuroblastoma.
Yan J; Jie L; Jiaxing Y; Yanna C; Zhanglin L; Zhongyuan L; Daowei W; Guangzong Z; Benfu Z; Jie Y; Qiang Z
Int J Med Sci; 2022; 19(11):1715-1723. PubMed ID: 36237985
[No Abstract] [Full Text] [Related]
2. [Effectiveness of autologous hematopoietic stem cell transplantation in the treatment of high-risk neuroblastoma in children: a single-center clinical study].
Wang LH; Chen K; Zhang N; Yang JW; Zhang T; Shao JB
Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):476-482. PubMed ID: 37272173
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Analysis of the Therapeutic Outcomes of 117 Neuroblastoma Patients Treated at a Single Pediatric Oncology Center in China.
Yu U; Xu H; Chen S; Yi M; Liu C; Zhang X; Wang C; Song J; Gan Y; Wang J; Wang Y; Zhang Q; Sun J; Xia B; Zhang G; Li C; Wen F; Liu S; Yuan X
Cancer Control; 2023; 30():10732748231187837. PubMed ID: 37575028
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation.
Yi ES; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
Pediatr Blood Cancer; 2020 Feb; 67(2):e28066. PubMed ID: 31736249
[TBL] [Abstract][Full Text] [Related]
5. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
Park JR; Kreissman SG; London WB; Naranjo A; Cohn SL; Hogarty MD; Tenney SC; Haas-Kogan D; Shaw PJ; Kraveka JM; Roberts SS; Geiger JD; Doski JJ; Voss SD; Maris JM; Grupp SA; Diller L
JAMA; 2019 Aug; 322(8):746-755. PubMed ID: 31454045
[TBL] [Abstract][Full Text] [Related]
6. Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
Streby KA; Parisi MT; Shulkin BL; LaBarre B; Bagatell R; Diller L; Grupp SA; Matthay KK; Voss SD; Yu AL; London WB; Park JR; Yanik GA; Naranjo A
Pediatr Blood Cancer; 2023 Aug; 70(8):e30418. PubMed ID: 37199022
[TBL] [Abstract][Full Text] [Related]
7. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
Tang SQ; Huang DS; Wang JW; Feng C; Yang G
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group.
Granger M; Grupp SA; Kletzel M; Kretschmar C; Naranjo A; London WB; Diller L
Pediatr Blood Cancer; 2012 Nov; 59(5):902-7. PubMed ID: 22744917
[TBL] [Abstract][Full Text] [Related]
9. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
Marcus KJ; Shamberger R; Litman H; von Allmen D; Grupp SA; Nancarrow CM; Goldwein J; Grier HE; Diller L
J Pediatr Hematol Oncol; 2003 Dec; 25(12):934-40. PubMed ID: 14663275
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Desai AV; Applebaum MA; Karrison TG; Oppong A; Yuan C; Berg KR; MacQuarrie K; Sokol E; Hall AG; Pinto N; Wolfe I; Mody R; Shusterman S; Smith V; Foster JH; Nassin M; LaBelle JL; Bagatell R; Cohn SL
Cancer; 2022 Aug; 128(15):2967-2977. PubMed ID: 35665495
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of high-dose
Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
[TBL] [Abstract][Full Text] [Related]
12. Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.
Saarinen-Pihkala UM; Hovi L; Koivusalo A; Jahnukainen K; Karikoski R; Sariola H; Wikström S
Pediatr Blood Cancer; 2012 Dec; 59(7):1190-7. PubMed ID: 22492714
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598
[TBL] [Abstract][Full Text] [Related]
14. Successful High-dose Chemotherapy in Combination With Autologous Peripheral Blood Stem Cell Transplantation in an Anuric Child With Neuroblastoma.
Inoguchi T; Hamada R; Kubota W; Terano C; Harada R; Honda M; Yamaoka S; Yokokawa Y; Yuza Y; Hataya H
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1156-e1158. PubMed ID: 33625080
[TBL] [Abstract][Full Text] [Related]
15. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L
J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928
[TBL] [Abstract][Full Text] [Related]
16. [Dose-enhanced immunochemotherapy followed by first-line autologous peripheral blood stem cell transplantation for young patients with high-risk aggressive B-cell lymphoma: an efficacy and prognostic factor analysis].
Wang Y; Liu W; Huang WY; Lyu R; Li J; Deng SH; Sui WW; Liu H; Wang TY; Yi SH; Liu HM; Qiu LG; Zou DH
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):215-220. PubMed ID: 35405779
[No Abstract] [Full Text] [Related]
17. Value of surgical resection in children with high-risk neuroblastoma.
Englum BR; Rialon KL; Speicher PJ; Gulack B; Driscoll TA; Kreissman SG; Rice HE
Pediatr Blood Cancer; 2015 Sep; 62(9):1529-35. PubMed ID: 25810376
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with
Suh JK; Koh KN; Min SY; Kim YS; Kim H; Im HJ; Namgoong JM; Kim DY; Ahn SD; Lee JJ; Seo JJ
Pediatr Transplant; 2020 Mar; 24(2):e13658. PubMed ID: 31960542
[TBL] [Abstract][Full Text] [Related]
19. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
